Mequitazine

This classification denotes an anti-allergic agent and bronchodilator with the molecular formula C20H22N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y463242LY2, chemically known as 10h-phenothiazine, 10-(1-azabicyclo(2.2.2)oct-3-ylmethyl)- (9ci) but generally known as mequitazine, which bears US NIH Compound Identifier 4066. European Medicines Agency schedules Mequitazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08766MIG. World Health Organization schedules mequitazine in its Anatomical Therapeutic Chemical (ATC) Classification. MEQUITAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mequitazine under HS 29343090 and SITC 51578. As of Q4 2014, MEQUITAZINE remains the US FDA Preferred Term for this commodity. SMILES: S1C2C(N(CC3C4CCN(C3)CC4)C3C1CCCC3)CCCC2.